IQVIA Holdings Inc BDR (I1QV34)

B3
Currency in BRL
220.00
0.00(0.00%)
Delayed Data·
I1QV34 Scorecard
Full Analysis
Management has been aggressively buying back shares
Trading near 52-week Low
Fair Value
Day's Range
220.00220.00
52 wk Range
220.00331.39
Key Statistics
Edit
Bid/Ask
200.00 / 226.67
Prev. Close
220
Open
220
Day's Range
220-220
52 wk Range
220-331.39
Volume
-
Average Volume (3m)
25
1-Year Change
-30.36%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
I1QV34 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
5 analysts have revised their earnings downwards for the upcoming period
Show more

IQVIA Holdings Inc BDR Company Profile

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.

Employees
88000
Market
Brazil

Compare I1QV34 to Peers and Sector

Metrics to compare
I1QV34
Peers
Sector
Relationship
P/E Ratio
19.1x15.2x−0.5x
PEG Ratio
6.930.120.00
Price/Book
4.3x1.4x2.6x
Price / LTM Sales
1.7x1.5x2.9x
Upside (Analyst Target)
-71.2%68.1%
Fair Value Upside
Unlock−23.0%10.4%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the IQVIA Holdings BDR (I1QV34) Stock Price Today?

The IQVIA Holdings BDR stock price today is 220.00

What Stock Exchange Does IQVIA Holdings BDR Trade On?

IQVIA Holdings BDR is listed and trades on the B3 stock exchange.

What Is the Stock Symbol for IQVIA Holdings BDR?

The stock symbol for IQVIA Holdings BDR is "I1QV34."

What Is the IQVIA Holdings BDR Market Cap?

As of today, IQVIA Holdings BDR market cap is 148.82B.

What is IQVIA Holdings BDR Earnings Per Share?

The IQVIA Holdings BDR EPS is 7.57.

From a Technical Analysis Perspective, Is I1QV34 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.